US company to develop DNA vaccines for fish

Published: March 11, 2008

Source : Fish Farmer Magazine

THE Texas-based biopharmaceutical company CytoGenix, Inc. has announced it has completed an agreement with Taiwan Cobia Inc. (TCI) to develop DNA vaccines against fish viruses.

Under this Agreement, CytoGenix will develop DNA vaccines against selected viruses and TCI will vaccinate the fish and test immunological responses.

Commenting, Cory Huang, president and chief executive officer of TCI, said that while aquaculture is one of the fastest growing food producing sectors in the world, it faces many challenges, especially when it comes to health management of fish stocks. He claimed CytoGenix’s synDNA™ technology has the capability to "provide the large quantities of affordable DNA vaccines necessary to address the need for simpler and more effective aquaculture vaccination regimens than currently available".

Founded in 2004, TCI says it was the first company to introduce the concept of organic aqua farming in Taiwan. The company is currently adding production sites in China and Southeastern Asia. Additionally, TCI has collaborative agreements with a number of research institutes and universities.

CytoGenix, Inc. is a Houston-based biopharmaceutical company pioneering the new field of gene based medicine.

Source